Actavis pharmaceutical company plans to boost exports by 10-15% next year as it enters new markets and launches new products.
“We plan to launch the first products in several South American
countries, such as Columbia, and northern Africa, Algeria, the
Middle East, as well as in Thailand, Hong-Kong or Greece. Overall,
we plan to have our products present in around 60 countries,” said
Bogdan Oghina, general manager of Sindan Pharma plant.
At present, the plant exports to 52 countries, and the biggest
volumes go to Japan, the US, Poland, Iran, Germany, France and
Bulgaria.
In the first nine months of 2010, Actavis Romania posted total
sales worth above 288m RON (69m euros). Exports had an over 23%
weight. “Compared with a year ago, we saw total turnover go down by
around 9%, a decrease that can be accounted for by price erosion,
caused both by industry rules, and the tightening competition,
particularly on the segment of cancer drugs,” said Alina Culcea,
general manager of Actavis Romania.